Capstone Holding Corp. — Director's Dealing 2011

Jan 13, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2011-01-11

Reporting Person: WARDELL WILLIAM M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-01-11	Common Stock	P	26500	$0.59	Acquired	143702	Direct
2011-01-12	Common Stock	P	2700	$0.56	Acquired	146402	Direct